140 related articles for article (PubMed ID: 5295035)
21. A cost-effective guide for the prevention of chemical phlebitis caused by the pH of the pharmaceutical agent.
Harrigan CA
NITA; 1984; 7(6):478-82. PubMed ID: 6568460
[No Abstract] [Full Text] [Related]
22. Suppurative phlebitis of an arm vein from a "scalp-vein needle".
Maki DG; Drinka PJ; Davis TE
N Engl J Med; 1975 May; 292(21):1116-7. PubMed ID: 1093020
[No Abstract] [Full Text] [Related]
23. Postinfusion phlebitis and in-line terminal membrane filtration.
Thayssen P; Kortegaard N; Winding O
Dan Med Bull; 1977 Sep; 24(4):160-2. PubMed ID: 336303
[No Abstract] [Full Text] [Related]
24. Final inline filtration: a means of decreasing the incidence of infusion phlebitis.
Bivins BA; Rapp RP; DeLuca PP; McKean H; Griffen WO
Surgery; 1979 Apr; 85(4):388-94. PubMed ID: 432800
[TBL] [Abstract][Full Text] [Related]
25. Prophylaxis against postinfusion phlebitis.
Fonkalsrud EW; Carpenter K; Masuda JY; Beckerman JH
Surg Gynecol Obstet; 1971 Aug; 133(2):253-6. PubMed ID: 5565353
[No Abstract] [Full Text] [Related]
26. Hazards associated with parenteral therapy.
Turco SJ
Bull Parenter Drug Assoc; 1974; 28(4):197-204. PubMed ID: 4852222
[No Abstract] [Full Text] [Related]
27. Infusion-related phlebitis.
N Engl J Med; 1985 May; 312(22):1452-5. PubMed ID: 3990747
[No Abstract] [Full Text] [Related]
28. Phlebitis and extravasation ("tissuing") with intravenous infusions.
Hecker JF; Fisk GC; Lewis GB
Med J Aust; 1984 May; 140(11):658-60. PubMed ID: 6717351
[TBL] [Abstract][Full Text] [Related]
29. The prevention and management of device-related infection in infusion therapy.
Maki DG
J Med; 1980; 11(4):239-53. PubMed ID: 6943256
[TBL] [Abstract][Full Text] [Related]
30. Heparin in the prevention of infusion phlebitis. A double-blind controlled study.
Daniell HW
JAMA; 1973 Dec; 226(11):1317-21. PubMed ID: 4586195
[No Abstract] [Full Text] [Related]
31. The future of intravenous therapy.
Wilmore DW
Am J Nurs; 1971 Dec; 71(12):2334-8. PubMed ID: 5209455
[No Abstract] [Full Text] [Related]
32. A comparison of the rate of complications with heparin-lock and keep-open I.V.'s.
Hanson RL
Commun Nurs Res; 1977 Mar; 8():188-200. PubMed ID: 585595
[No Abstract] [Full Text] [Related]
33. Phlebitis complicating central venous infusion.
Laucks SS; Kukrika MD
Pa Med; 1986 Mar; 89(3):62, 64. PubMed ID: 3960550
[No Abstract] [Full Text] [Related]
34. [Risks of long-term intravenous infusions with indwelling polyethylene catheters].
Nasilowski W; Meissner A; Bukowska D
Pol Tyg Lek; 1973 Sep; 28(38):1470-3. PubMed ID: 4750071
[No Abstract] [Full Text] [Related]
35. A survey of intravenous cannula use at Presbyterian Hospital, Oklahoma City.
Sexton DJ; Gravney SJ
J Okla State Med Assoc; 1982 Mar; 75(3):62-5. PubMed ID: 7086555
[No Abstract] [Full Text] [Related]
36. Infection from indwelling catheters--a disease of good medicine.
Nahum LH
Conn Med; 1971 Aug; 35(8):505. PubMed ID: 5564744
[No Abstract] [Full Text] [Related]
37. Relationship between incidence of phlebitis and frequency of changing IV tubing and percutaneous site.
Nichols EG; Barstow RE; Cooper D
Nurs Res; 1983; 32(4):247-52. PubMed ID: 6553250
[TBL] [Abstract][Full Text] [Related]
38. In-line I.V. filters. Are they really worthwhile?
Parent B
Nursing; 1981 Aug; 11(8):58-60. PubMed ID: 6910603
[No Abstract] [Full Text] [Related]
39. Intravenous therapy team and peripheral venous catheter-associated complications. A prospective controlled study.
Tomford JW; Hershey CO; McLaren CE; Porter DK; Cohen DI
Arch Intern Med; 1984 Jun; 144(6):1191-4. PubMed ID: 6375611
[TBL] [Abstract][Full Text] [Related]
40. Complications with heparin-lock needles.
Couchonnal GJ; Hodges GR; Barnes WG; Elmets CA; Clark GM
JAMA; 1979 Nov; 242(19):2098-100. PubMed ID: 490790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
